PLx Pharma Winddown Corp. Deferred Tax Assets, Valuation Allowance
PLx Pharma Winddown Corp. had Deferred Tax Assets, Valuation Allowance of $37.46 million as of 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2022-03-11
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $37.46M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $31.05M; Deferred Tax Assets, Valuation Allowance as first filed $31.05M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $26.73M.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $17.82M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2021-12-31 | $37.46M 10-K · filed 2022-03-11 | |
| 2020-12-31 | $31.05M 10-K · filed 2022-03-11 | $31.05M 10-K · filed 2021-03-12 |
| 2019-12-31 | $26.73M 10-K · filed 2021-03-12 | |
| 2018-12-31 | $17.82M 10-K · filed 2020-03-13 | |
| 2017-12-31 | $16.13M 10-K · filed 2019-03-08 | |
| 2016-12-31 | $2.44M 10-K · filed 2018-03-23 | $17.96M 10-K · filed 2017-01-20 |
| 2015-12-31 | $14.58M 10-K · filed 2017-01-20 | |
| 2014-12-31 | $5.89M 10-K · filed 2016-03-22 |